Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
In total 20 subjects will be enrolled at one participating site -UMC Ljubljana. The 20 subjects will be treated with placebo and NBMI 300 mg in a cross-over design. In case of subject drop-outs, additional subjects may be enrolled as decided by the Sponsor, to allow for expected number of evaluable subjects in each group.
Epistemonikos ID: 6dc22a6d155174d56728248c6d46ab6dd37004da
First added on: May 06, 2024